The distribution of T‐cell subsets and the expression of immune checkpoint receptors and ligands in patients with newly diagnosed and relapsed acute myeloid leukemia-Reference-Cited by-同舟云学术

The distribution of T‐cell subsets and the expression of immune checkpoint receptors and ligands in patients with newly diagnosed and relapsed acute myeloid leukemia

Published:2018-11-30 Issue:9 Volume:125 Page:1470-1481
ISSN:0008-543X
Container-title:Cancer
language:en
Short-container-title:Cancer

Author:

Williams Patrick¹,Basu Sreyashi²,Garcia‐Manero Guillermo³,Hourigan Christopher S.⁴,Oetjen Karolyn A.⁴,Cortes Jorge E.³,Ravandi Farhad³,Jabbour Elias J.¹,Al‐Hamal Zainab²,Konopleva Marina³,Ning Jing⁵^ORCID,Xiao Lianchun⁵^ORCID,Hidalgo Lopez Juliana⁶,Kornblau Steve M.³,Andreeff Michael³,Flores Wilmer³,Bueso‐Ramos Carlos⁶,Blando Jorge²,Galera Pallavi⁷,Calvo Katherine R.⁷,Al‐Atrash Gheath⁸,Allison James P.²,Kantarjian Hagop M.³,Sharma Padmanee²,Daver Naval G.³

Affiliation:

1. Department of Cancer Medicine The University of Texas MD Anderson Cancer Center Houston Texas

2. Immunotherapy Platform The University of Texas MD Anderson Cancer Center Houston Texas

3. Department of Leukemia The University of Texas MD Anderson Cancer Center Houston Texas

4. Laboratory of Myeloid Malignancies, Hematology Branch National Heart, Lung, and Blood Institute, National Institutes of Health Bethesda Maryland

5. Department of Biostatistics The University of Texas MD Anderson Cancer Center Houston Texas

6. Department of Hematopathology The University of Texas MD Anderson Cancer Center Houston Texas

7. Department of Laboratory Medicine National Institutes of Health Clinical Center Bethesda Maryland

8. Department of Stem Cell Transplant and Cell Therapy The University of Texas MD Anderson Cancer Center Houston Texas

Funder

National Cancer Institute

National Institutes of Health

Publisher

Wiley

Subject

Cancer Research,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/cncr.31896

Reference51 articles.

1. Nivolumab versus Docetaxel in Advanced Nonsquamous Non–Small-Cell Lung Cancer

2. Improved Survival with Ipilimumab in Patients with Metastatic Melanoma

3. Naive and effector CD4 T cells differ in their requirements for T cell receptor versus costimulatory signals;Dubey C;J Immunol,1996

4. PD-1 Blockade with Nivolumab in Relapsed or Refractory Hodgkin's Lymphoma

5. Nivolumab for classical Hodgkin's lymphoma after failure of both autologous stem-cell transplantation and brentuximab vedotin: a multicentre, multicohort, single-arm phase 2 trial

Cited by 228 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. PD-L1 and PD-1 in immune regulation and their implications in blood cancers;Advances in Cancer Biology - Metastasis;2024-10

2. Immune‐dysregulation harnessing in myeloid neoplasms;Cancer Medicine;2024-09

3. Evolution of T-cell fitness through AML progression: enhanced bispecific T-cell engager-mediated function of bone marrow T cells at remission compared to initial diagnosis and relapse;Leukemia;2024-08-22

4. Anti-PD-1 combined with hypomethylating agent and CAG regimen bridging to allogeneic hematopoietic stem cell transplantation: a novel strategy for relapsed/refractory acute myeloid leukemia;Frontiers in Immunology;2024-08-16

5. Low frequency of Vγ9Vδ2 T cells predicts poor survival in newly diagnosed acute myeloid leukemia;Blood Advances;2024-08-14